Malignant Extrahepatic Bile Duct Neoplasm

Malignant Extrahepatic Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

162 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 3%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–20 of 20 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06420349	NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma	terminated	Phase 1	7	Mayo ClinicOTHER	1	Dec 22, 2025	clinicaltrials
NCT04561453	Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer	terminated	—	14	University of WashingtonOTHER	1	Jul 10, 2025	clinicaltrials